EMA: Covid-19 Vaccine of AstraZeneca Linked to Rare Spinal Condition
According to a safety panel of the European Medicines Agency has recommended that, adding a rare spinal inflammation known as the transverse myelitis as a side effect of the novel corona virus vaccine of AstraZeneca. The corona virus vaccine developed by AstraZeneca have been facing the several setbacks that is also including the delays and […]
Continue Reading